Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VIBEGRON for Benign prostatic hyperplasia: Side Effects & Safety Data

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

There are 6 adverse event reports in the FDA FAERS database where VIBEGRON was used for Benign prostatic hyperplasia.

Most Reported Side Effects for VIBEGRON

Side Effect Reports % Deaths Hosp.
Drug ineffective 732 16.0% 0 5
Inability to afford medication 267 5.8% 0 2
Urinary retention 223 4.9% 2 24
Headache 218 4.8% 0 4
Diarrhoea 215 4.7% 0 5
Urinary tract infection 184 4.0% 2 25
Pollakiuria 171 3.7% 0 4
Therapeutic product effect incomplete 167 3.7% 0 2
Urinary incontinence 166 3.6% 0 4
Product availability issue 164 3.6% 0 7
Nocturia 155 3.4% 0 5
Constipation 140 3.1% 1 10
Nausea 129 2.8% 1 8
Drug effect less than expected 125 2.7% 0 1
Therapeutic product effect decreased 113 2.5% 0 1

Other Indications for VIBEGRON

Product used for unknown indication (1,996) Hypertonic bladder (1,406) Urinary incontinence (213) Pollakiuria (140) Incontinence (126) Micturition urgency (95) Bladder disorder (70) Nocturia (46) Urge incontinence (17) Bladder spasm (16)

Other Drugs Used for Benign prostatic hyperplasia

TAMSULOSIN (3,156) TADALAFIL (1,154) FINASTERIDE (1,104) DUTASTERIDE (1,004) ALFUZOSIN (849) SILODOSIN (628) DUTASTERIDE\TAMSULOSIN (313) DOXAZOSIN (219) HERBALS\SAW PALMETTO (181) MIRABEGRON (93)

Related Pages

VIBEGRON Full Profile All Benign prostatic hyperplasia Drugs VIBEGRON Demographics VIBEGRON Timeline